CorporateProduction Capacity Change2026-05-15🇮🇳
Sanjivani Parenteral reports FY26 full-year results: EBITDA Rs 114 mn
source: Sanjivani Parenteral Limited
On 2026-05-15, Sanjivani Parenteral Limited said commercial production had commenced at its newly established IV Fluid Infusion Plant in Pune. The company described the facility as a milestone in strengthening manufacturing capabilities and expanding its healthcare product portfolio.
0.13Significance2.0Magnitude0.1Systemic0.1Market1Articles
Location
PuneMaharashtraSouth AsiaIndiaAsia18.520, 73.857
Story Links